Funded Tech Companies
Basilea Pharmaceutica
Basilea Pharmaceutica is a biopharmaceutical company, based in Allschwil. Venture investment and financing came from Biomedical Advanced Research and Development Authority and Carb-X.
Company Overview
Company Name
Basilea Pharmaceutica
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Hegenheimermattweg 167b
Allschwil, 4123
Switzerland
Allschwil, 4123
Switzerland
Phone
Website
Email Address
Company Background Information
Overview
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea has about 190 employees. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands, Cresemba® for the treatment of invasive fungal infections and Zevtera® for the treatment of bacterial infections. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/29/2026
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Veitch
Chief Financial Officer
Adesh Kaul
Chief Medical Officer
Marc Engelhardt
Chief Scientific Officer
Laurenz Kellenberger
Chief Technical Officer
Gerrit Hauck
VP - General Counsel
Damian Heller
VP - Human Resources
Ursula Eberhardt
VP - Regulatory Affairs
Peter Bielmeier
VP - Regulatory Affairs
Mark Jones
Company Investors
- Biomedical Advanced Research and Development Authority
- Carb-X (Richard Alm)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs